Stock 4594 BRIGHTPATH BIOTHERAPEUTICS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart BrightPath Biotherapeutics Co., Ltd.

Equities

4594

JP3274140007

Delayed Japan Exchange
Other stock markets
 08:33:22 2024-05-21 pm EDT 		5-day change 1st Jan Change
61 JPY +1.67% Intraday chart for BrightPath Biotherapeutics Co., Ltd. +3.39% -29.89%
2023 BrightPath Biotherapeutics Co., Ltd. announced that it has received ¥5.1678 million in funding from Macquarie Group Limited CI
2023 BrightPath Biotherapeutics Co., Ltd. announced that it expects to receive ¥5.1678 million in funding from Macquarie Group Limited CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
BRIGHTPATH BIOTHERAPEUTICS CO., LTD. Stock BrightPath Biotherapeutics Co., Ltd.
 26.74M - - - - -
MODERNA, INC. Stock Moderna, Inc.
 54.04B -
LONZA GROUP AG Stock Lonza Group AG
 41.96B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 41.92B
CELLTRION, INC. Stock Celltrion, Inc.
 28.35B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
 26.35B
  1. Stock Market
  2. Equities
  3. 4594 Stock
  4. Charts BrightPath Biotherapeutics Co., Ltd.
  5. Sector Chart
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW